Welcome to GSKPro UK

For UK healthcare professionals - information on GSK's medicines and vaccines, educational resources and more.
DNA

Webshop

Support your patients and practice with these healthcare resources. Delivery is free on all orders.

Relevant Prescribing Information is available below within resource boxes. Adverse Event reporting statement can be found at the bottom of this page.

Filter
Product
Product:
Digital Desktop COPD Action Planner
 Digital
April 2026 | PM-GB-RS-WCNT-260004 (V1.0)
Digital Desktop COPD Action Planner
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Desktop COPD Symptom Tracker
 Digital
April 2026 | PM-GB-RS-WCNT-260005 (V1.0)
Digital Desktop COPD Symptom Tracker
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Mobile COPD Action Planner
 Digital
April 2026 | PM-GB-RS-WCNT-260003 (V1.0)
Digital Mobile COPD Action Planner
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Mobile COPD Symptom Tracker
 Digital
April 2026 | PM-GB-RS-WCNT-260006 (V1.0)
Digital Mobile COPD Symptom Tracker
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Ellipta demonstration device
 Physical
May 2026 | PM-GB-RS-WCNT-200028 (v3.0)
Ellipta demonstration device
Demonstration device for healthcare professionals to show patients how to use the Ellipta device correctly.
Prescribing Information
Ellipta Inhalation Trainer
 Physical
May 2026 | PM-GB-RS-WCNT-200035 (v4.0)
Ellipta Inhalation Trainer
Training whistle that helps patients understand the correct inspiratory flow needed to use the Ellipta device.
Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.

December 2024 | PM-GB-NA-WCNT-240001 (V2.0)